Cargando…
Treatment mechanism of immune triad from the repurposing drug against COVID-19
COVID-19 is an immune-mediated disease whose pathophysiology uses SAMHD1 tetramerization and cGAS–STING signaling, toll-like receptor 4 (TLR4) cascade, spike protein– inflammasome activation, and neuropilin 1 (NRP1) signaling. Variants of concern, such as SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290163/ https://www.ncbi.nlm.nih.gov/pubmed/37388715 http://dx.doi.org/10.1016/j.tma.2023.06.005 |